Treating Pleural Empyema in Community-Acquired Infection with a History of Penicillin Allergy
Community-acquired pleural infection presenting in a patient with a documented history of penicillin allergy requires a modified antibiotic strategy. Standard penicillin-based empirical regimens are not appropriate in this setting, and an alternative approach must cover the expected pathogen spectrum.
Clinical scenario: Community-acquired pleural infection in a patient with penicillin allergy. Empirical therapy must target both Gram-positive aerobes and anaerobes while avoiding penicillin-class agents, until culture results are available.
Treatment approach — partial overview
Management involves empirical clindamycin-based antibiotic therapy as a penicillin-sparing alternative, combined with prompt intercostal chest drain insertion.
The full combination options, step-down criteria, and treatment course are available in the complete protocol.
Treatment target: Clinical improvement — defined as cessation of pyrexia, resolution of inflammatory markers, and radiological improvement — guiding the transition from intravenous to oral antibiotics.
References
DOI: 10.1183/20734735.0146-2023
- In the community-acquired infection setting, treatment should target both Gram-positive aerobes and anaerobes until results of cultures become available.
- For patients that are penicillin-allergic, clindamycin alone, or in combination with ciprofloxacin or a cephalosporin, is likely to provide a good alternative.
- Immediate management with intercostal drainage is recommended.
- Current British Thoracic Society guidelines recommend stepping down from intravenous to oral antibiotics when there has been "clinical improvement", which is defined as cessation of pyrexia, resolution of inflammatory markers, and radiological improvement.
- Usually, 5–7 days of intravenous antibiotics are sufficient to achieve these criteria in most cases.
View source ↗